TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Levels of IgG antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Deviation from recommended dosing regimens
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cmax of DRSP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC(0-72 h) of drospirenone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum azacitidine plasma concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration‐time curve (AUC∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Math scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Overall adaptive functioning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: mean error in inclination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean error in anteversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of infants requiring intervention for PDA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ductal size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: analgesic impact
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: support and social connection
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: creative problem solving
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: attending to pandemic-related symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Social Anxiety Disorder (SAD) symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: median clinical recovery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median time to defervescence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of open ulcer weeks per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neonatal behavioral neurological assessment (NBNA) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: recovery time of consciousness, muscle tension, and reflex
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medical skepticism score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: early initiated breastfeeding within 2 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: exclusive breastfeeding during hospital stay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuropathic pain prevalence at six months post-injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical disability (DRI adjusted mean difference)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Newborn 25(OH)D levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Newborn zinc levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: phonemic verbal fluency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: semantic verbal fluency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: motor impulsivity control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hunger
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Circulating levels of GLP-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Bone bending strength (section modulus)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of AI classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of AI and manual grading
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Workload alleviation of manual grading
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: NICU admission frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of moderate-severe HIE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Mean bilateral MLMT change scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in full‐field light sensitivity threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in Goldmann kinetic VF III4e sum total degrees
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: safety of anterior temporal lobectomy
Endpoint domain: Adverse events/effects
Primary endpoint: efficacy of anterior temporal lobectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 48-hour morphine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of morphine-related side effects (nausea)
Endpoint domain: Adverse events/effects
Primary endpoint: functional walking performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Depressive risk
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: depression and anxiety literacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: intentions to seek help from formal sources
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: confidence to seek mental health information
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: NRS pain scores during hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of postoperative salvage analgesics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: postoperative hospitalization days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: self‐rating anxiety scale scores (SAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: self‐rating depression scale (SDS) scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: total Pittsburgh sleep quality index (PSQI) scores
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Number of OctaplasLG® units given
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Relapse of MA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: objective oral status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of mesh erosion at 12 months
Endpoint domain: Adverse events/effects
Primary endpoint: Perceived distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived height of self-illuminated target
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scores of gastrointestinal disease symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Improvement of intestinal mucosal barrier function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Improvement of inflammatory response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement of immunity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Recovery rates at Day 5 and Day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median cumulative AVB time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median length of stay in intensive care unit (ICU)
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Risk of heart failure (HF) or cardiac death
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of neonates requiring phototherapy again
Endpoint domain: Adverse events/effects
Primary endpoint: self-reported planning/organisation ability
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cartilaginous thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Healing process of CVUs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of resuscitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Students' satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Understanding of dermatology and venereology content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scores on case analysis questions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lysholm score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Post-tonsillectomy hemorrhage rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative visits to the ER
Endpoint domain: Adverse events/effects
Primary endpoint: EORTC QLQ functional scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: EORTC QLQ global scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: EORTC QLQ symptom subscale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of oxygenation-impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GLCM homogeneity slope
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GLCM contrast slope
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GLCM correlation slope
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of bone height resorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of new bone formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of CIT based on platelet count
Endpoint domain: Adverse events/effects
Primary endpoint: Chemotherapy dose delay due to CIT AEs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Velocity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elbow angle at the end of movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of hiatal hernia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: brachial systolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: plasma NO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MHS utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: breastfeeding duration
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: repeat pregnancy rates
Endpoint domain: Mortality/survival
Endpoint subdomain: null
Primary endpoint: Lower limb function improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postdilation IOP elevation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Acute angle closure (AAC) incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in numerical rating scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caregivers' self-esteem
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Post-test outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intervention group outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion time for sessions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Physical Activity changes from baseline to 12-month follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Benefit Rate (CBR) at 16 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity for detecting CIN3+
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of CKD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: CKD stage progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: RBS-R improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Teachers' implementation fidelity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful completion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Light quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Space maintenance after early extraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relational memory performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IGA score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of identifiable BCTs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TICI 2B/3 reperfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality from cancer or CVDs
Endpoint domain: Mortality/survival
Primary endpoint: WSRS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FACE-Q scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: dark-adapted Rod bwave amplitude reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of 1-year bleeding events
Endpoint domain: Adverse events/effects
Primary endpoint: HRV index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean scar grading
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scar length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scar coloring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduced positive perceptions of recent cigarettes smoked
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased quitting cognitions
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in CAT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in LVM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hydration of the stratum corneum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Increase in fasting blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Euroqol-5D
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total CCFN (H3) concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in IPSS QoL score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Improvement in IIEF score
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Pocket probing depths for the distobuccal surface of the second molar
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PBAC score under 75
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PBS use intentions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in SMI at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Slower myopia progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduced axial growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in subfoveal choroidal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean decrease in wound size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transverse magnification changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS score on the first day after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: worsening kidney function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Fibro-inflammatory profile improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardiovascular remodelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in peakV�O2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: common extensor tendon thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: radial nerve cross sectional area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Serum β‐HCG levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Major adverse cardiac events (MACEs)-free survival
Endpoint domain: Mortality/survival
Primary endpoint: upper limb Fugl‐Meyer scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Ashworth scales scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall VAS score improvement
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: VAS for pain improvement
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Overall survival associated with VAS scores
Endpoint domain: Mortality/survival
Primary endpoint: Glucose variability (GV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: overall head and neck anatomy knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative quality indicator performance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: daily minutes of moderate to vigorous physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in Lp-PLA2 activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Decrease in ox-LDL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: milk thiamine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum pain score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: opioid-free patients after PENG block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IGF1 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Basal blood levels of IGF1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: confidence in performing patient assessments
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Severity of acne scars
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: number of gout flares at 9 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gout medication side effects at 3 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: unmet gout treatment need at 3 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: cognitive stimulation
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: awareness about the importance of early reading
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: increased vocabulary
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: New KS diagnosis rates
Endpoint domain: Mortality/survival
Primary endpoint: Incorrect KS diagnosis rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 90-day return rates
Endpoint domain: Mortality/survival
Primary endpoint: WM performance enhancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ODI4 (Oxygen Desaturation Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: relative peak power output (PPO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relative mean power output (MPO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ATP-PCr resynthesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain related to wearing the cast or boot
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social isolation and disruption to daily life routines
Endpoint domain: Life impact
Endpoint subdomain: Social functioning